Checklists

Checklist for Medical Device Registration Class II Devices – Equivalency route (MHLW)

Submission requirements

Notes

Supporting Documents

2. Address where the device is physically manufactured
3. Locations of the places where the device will be shipped from (countries)
4. Distributor list in Mexico, if known at this time
If distributors will not be added to the registration at this time, they must be added later through a modification process.
5. Warehouses Notice and Health Quality Manager Notice
All Mexican distributors are legally required to have these noties. An electronic copy of the notices is sufficient for the registration.
  1. veraqueconsulting.com/mx/requirements-for-a-proper-medical-devices-warehouse-in-mexico/
  2. veraqueconsulting.com/mx/nom241-for-medical-device-good-manufacturing-practices-in-mexico/
6. Power of Attorney
Issuing authority to the legal representative in order to apply for renewals and/or registration submissions to COFEPRIS. An original or certified copy is required.
8. Labels that will be used for products imported to Mexico and Labels design.
Labels must be in Spanish and should meet the requirements of the Mexican Labeling Norm NOM-137-SSA1-2008. Whenever Mexican Labels are not yet finalized and compliant, it is necessary to prepare and submit the Label Design.
  1. veraqueconsulting.com/mx/about-labeling-requirements-for-medical-devices-in-mexico/
9. Instructions for use, leaflet or operation manual, as applicable (in Spanish)
At least the following information must be provided: Name, Description of the product, intended use and directions of use, list of product components or parts, assembly and disassembly instructions, operating and clean up instructions, operation conditions and storing, warnings, cautions, contraindications and adverse events, other as applicable (maintenance, calibration, preparation), for contrast media, indicate route of administration, pharmaceutical form and content of active ingredient per dose unit.
10. Technovigilance Report
Report summarizing latest post marketing surveillance of the product. It includes all adverse events recorded since the product was first made available on the market (if applicable). It also includes the corrective and preventive actions taken.
  1. veraqueconsulting.com/mx/technovigilance-for-medical-devices-in-mexico/
11. Risk Analysis
Issued in the design/development of the medical device, demostrating foreseen adverse incidents which should be included in the labels, IFU and/or Operating Manual. This doesn't need to be submitted to COFEPRIS, but it needs to be kept on file by the Mexican Registration Holder.
12. Representation letter issued by the manufacturer
You will receive the template for the letter from the consultant during the dossier compilation process. Original or Certified Copies are required.
  1. veraqueconsulting.com/mx/mexican-registration-holder-ultimate-guide/
13. Distribution letter
You will receive the template for the letter from the consultant during the dossier compilation process. Original or Certified Copies are required.
14. Free Sale Certificate
Coded certificate issued within the last year, including the device to be registered before COFEPRIS. Original or Certified copy
  1. veraqueconsulting.com/mx/certificate-of-free-sales-issued-by-cofepris-and-requirements/
  2. veraqueconsulting.com/mx/what-cofepris-requires-for-the-certificate-of-free-sale/
15. Export Notification
It must include: description, intended of use, codes or presentations, formula and/or compositions when applicable, shelf life when applicable, sterility period, primary and secondary packaging description.
  1. veraqueconsulting.com/mx/certificate-of-free-sales-issued-by-cofepris-and-requirements/
  2. veraqueconsulting.com/mx/mdsap-and-how-to-use-it-in-mexico/
16. Certificate issued by the Registered Certification Body.
It must include: description, intended of use, codes or presentations, formula and/or compositions, shelf life, when applicable, sterility period, primary and secondary packaging description.
  1. veraqueconsulting.com/mx/mdsap-and-how-to-use-it-in-mexico/
17. Approval letter issued by the MHLW
It must include: description, intended of use, codes or presentations, formula and/or compositions, shelf life, when applicable, sterility period, primary and secondary packaging description.
  1. veraqueconsulting.com/mx/mdsap-and-how-to-use-it-in-mexico/